Alexandre Giannecchini Romagnolo

Bachelor's degree in Biomedical Sciences from the Institute of Biosciences of Botucatu UNESP (2016), Masters degree in Research and Development in Medical Biotechnology from the Botucatu Medical School UNESP (2019), and Ph.D. in Health Sciences from Hospital Israelita Albert Einstein (2024). Currently a postdoctoral fellow at the Israeli Institute of Education and Research (IIEP) at Hospital Israelita Albert Einstein. Works on the development of animal models of melanoma for the study of immunotherapies using human cells genetically modified with CRISPR/Cas9. The Ph.D. research focused on alterations in the metabolomic profile and immune response during acute dengue virus infection. During undergraduate studies, participated in the Science Without Borders Program (GS/CSF GRADUAÇÃO SANDUÍCHE), funded by CAPES, at Brown University (USA) in 2014. In the final year of the undergraduate program, focused on immunology, conducting research on the role of the Dectin-1 receptor in human monocytes during fungal infections. The Masters degree was awarded for the development of immunosensor prototypes for human blood type classification. Experienced in cell culture, molecular biology, flow cytometry, monoclonal antibody production and purification, and development of immunosensor prototypes. (Source: Lattes Curriculum)